Abstract. The paper presents the case history of a Is-year-old boy with traumatic tetraplegia who developed hypercalcaemia within 6 weeks of injury. The condition was initially controlled by the infusion of intravenous fluids in large amounts and by the administration of calcitonin. Mter 3 weeks, calcitonin became ineffective. Eventually the hypercalcaemia responded to cortisone administered in low dosage. The endo crinologic implications of this observation are discussed.
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thereafter it remained close to normal throughout most of the hospital stay. The serum calcium began to diminish rapidly. On the 25th hospital day when it had fallen to 10'0 mg per cent the intravenous fluids were discontinued ( Fig. 1 ). On the 21st day calcitonin was added to the treatment in a dosage of 100 units twice a day. After 10 days the dosage was doubled to 200 units twice a day. The initial response was gratifying. The serum calcium fell and remained close to normal limits for 3 weeks. After that period of time it again rose and it remained elevated in spite of continuing calcitonin adminis tration (Fig. I ). Oral phosphate, in the form of 3 to 5 ml of Fleet's Phosphosoda, was given simultaneously with the calcitonin from the 79th to the I28th day. This proved ineffective, especially since the patient frequently refused to take this medication which made him nauseated. After the calcitonin had been discontinued the anabolic steroid stanozolol was administered in a daily dosage of 4 mg. It had no discernible effect on the serum calcium which remained elevated, varying between I I and 14 mg per cent. The patient's general condition improved nevertheless. He ate with a better appetite, he was able to be up in the wheelchair for several hours a day and to participate in rehabilitation activities. In order to achieve some weight-bearing on his lower extremities he was placed on a tilt table for brief periods each day. These attempts were frustrated by frequent bouts of orthostatic hypotension. The mineral corticosteroid fludrocortisone o· I mg was given daily with only partial relief.
In a further effort to reduce the serum calcium sodium fluoride in a dosage of 20 mg three times a day was given from the 153rd hospital day on and continued for 100 days. This measure also proved to be ineffective. An investigation of parathyroid function gave no evidence of hyperparathyroidism (Table II) . Most surprising was the discovery of a low plasma cortisol level of 3'4 mcg/loo ml (normal 8-24 mcg). Since there is evidence that the synthesis of prostaglandins is increased in adrenocortical insufficiency and since these compounds are known to enhance bone resorption indo methacin, 25 mg three times a day, was given for 10 days in order to suppress prosta glandin synthesis. During this period the serum calcium level fell from 13'5 to 12'3 mg per cent (Fig. 2 ).
An ACTH (cosyntropin) stimulation test indicated the presence of adrenocortical insufficiency. This was further supported by the elevation of the blood ACTH level (Table III) . In response to these findings treatment with cortisone acetate 37'5 mg per day was initiated and maintained for 2 weeks. The serum calcium began to decline promptly and fell as low as I 1'1 mg per cent. After cortisone was discontinued the serum calcium again rose to 13'4 mg per cent. After 18 days cortisone administration was resumed, and the serum calcium again fell to a low of 10·6 mg per cent (Fig. 2) .
Serum phosphorus levels remained within normal limits throughout his stay in the hospital. Creatinine clearance determinations were done several times and indicated 
reduced renal function. Serum creatinine and blood urea nitrogen remained normal. The serum electrolytes were normal. However, potassium supplements had to be given at various times to prevent a significant lowering of the serum potassium. Egg-shell type bladder calculi were crushed and removed by cystoscopy on two occasions, on the 1 loth and 297th hospital day. Intravenous pyelograms, at two occasions, showed a normal excretion of dye and a normal kidney structure. There were no stones in the renal pelves and no calcifications in the renal parenchyma.
The patient was discharged from the hospital on the 30lst hospital day. He will be maintained on cortisone acetate 37'5 mg a day for 5 days each week. His general condition was satisfactory at the time of discharge.
Discussion
Immobilisation hypercalcaemia was first reported by Albright et al. (1941) .
Their patient, a 14-year-old boy, developed osteoporosis, hypercalcaemia, hyper calcuria and renal failure during immobilisation for a fractured femur. He under went two neck explorations in a futile search for parathyroid tumours. Since then additional cases have been reported sporadically. The literature has been thoroughly reviewed by Lawrence et al. (1973) , and by Wolf et al. (1976) . In his review, Wolf et al. had found only 31 reported cases. Additional case reports have since appeared (Claus-Walker et al., 1975; Henke et al., 1975; Levine et al., 1975; Maynard & Imai, 1977) .
In almost all instances immobilisation hypercalcaemia has occurred in male adolescents who became immobilised suddenly following a life of intense physical activity. In such patients, as well as patients with Paget's disease and hyper thyroidism, both bone formation and resorption are elevated but balanced. Immobilisation diminishes bone formation while the rate of resorption is increased.
Hypercalcaemia occurs if sufficient calcium is released from bone into the blood at a rate greater than the capacity of the kidney to excrete the increased filtered load.
The hypercalcaemia may be asymptomatic but often it is associated with nausea, vomiting, constipation, abdominal cramps, weakness, lethargy, emotional instability and headaches. Encephalopathy, coma and death may ensue. The onset may occur early after immobilisation or there may be a delay of 1 to 3 months. Impairment of renal function has been reported by most observers and has been extensively studied by Hyman (1972) . His patient, a 15-year-old boy, was found to have a decreased glomerular filtration rate, creatinine clearance and urine concentrating ability. The urinary excretion of calcium was elevated, the tubular reabsorption of phosphorus was decreased. A metabolic alkalosis developed. After 9 months all renal function tests had returned to normal following mobilisation of the patient.
The elevated serum calcium obviously suggests the possibility of hyper parathyroidism. However, in all reported cases with one exception (Henke et at., 1975) parathyroid hormone blood levels have been normal. This has also been true for our patient. Furthermore, the favourable response to glucocorticoids militates against hyperparathyroidism. The condition is self-limited and disappears when the patient is mobilised. Unfortunately, this is often not possible in patients with spinal cord injury. The initial treatment consists of the administration of large amounts of sodium con taining intravenous fluids in order to promote calcium diuresis. Furosemide may be added to this regime. The serum potassium level must be monitored, and supplementary potassium should be given as needed. Oral phosphates increase bone formation and may also be of benefit. However, as was true for our patient, they are often poorly tolerated and are frequently refused.
Calcitonin decreases bone resorption, and for this reason it may be expected to benefit in the therapy of hypercalcaemia. However, in various animal studies calcitonin failed to prevent the development of disuse osteoporosis (Chiroff & Jowsey, 1970; Braddom et at., 1973) . Hantman et al. (I973) studying the calcium metabolism of healthy volunteers on bedrest found that the administration of calcitonin alone without mineral supplements actually causes an increase of urinary calcium excretion, possibly due to an inhibition of tubular calcium reabsorption. Both Hantman and other investigators have suggested that the prolonged adminis tration of calcitonin may stimulate excessive parathyroid action which cancels out the bone-sparing effect of calcitonin. In any case, in our patient calcitonin lowered the serum calcium level only during the first 3 weeks and was ineffective thereafter. Urinary calcium excretion, presented in Figure I in per cent of 24-hour creatinine excretion (calcium/creatinine x 100) fell during the first weeks of calcitonin administration and then rose again.
Anabolic steroids may be expected to decrease hypercalcuria and hyper calcaemia by increasing bone formation. The hormone stanozolol which we gave to our patient was ineffective, at least in the dosage in which it was employed.
Glucocorticoids have been effective in reducing serum calcium levels in the hands of all observers who have used them. The mechanism of action is not fully understood. Even though ordinarily adrenal corticosteroids cause osteo porosis when given in large doses and for prolonged periods of time they appear to reduce the excessive bone resorption encountered during immobilisation. Furthermore, their action may be partly due to a decrease of renal tubular reabsorp tion of calcium and to an expansion of the extracellular fluid compartment. Most observers have employed corticosteroids in large doses. The potential side effects of lowering the resistance to infection and enhancing the tendency to tissue break down are hazardous in young, chronically ill tetraplegic patients and kept us from using this form of treatment.
The low plasma cortisol level suggested that we were dealing with an adrenal cortical insufficiency, and this impression was further supported by the results of the ACTH stimulation test. As a result we elected to use cortisone in a small dosage, as a replacement for insufficient endogenous cortisol production. The immediate and significant drop of the serum calcium in response to 37·5 mg of cortisone a day supported this assumption. When cortisone was discontinued for 18 days, the serum calcium rose to hypercalcaemic levels. It again fell promptly when cortisone administration was resumed.
A review of the literature uncovered only one reference in support of our assumption that adrenocortical impairment may be at least a contributing factor to the development of immobilisation hypercalcaemia. Claus-Walker et al. (1975) found a decrease of 24-hour I7-ketosteroid excretion in two patients with im mobilisation hypercalcaemia in whom these determinations were made.
Hypercalcaemia has been observed in Addison's disease. Pedersen reported high serum calcium levels in two patients with this disorder. The hypercalcaemia responded promptly to replacement doses of cortisone (Pedersen, 1967) . Siegler (1970) has reported one such case and Leeksma et al. (1957) also found high serum calcium levels in patients with Addison's disease. The evidence for a causal relationship between adrenocortical insufficiency and immobilisation hyper calcaemia is tenuous so far. We hope that future observers will investigate the adrenocortical function in immobilised patients who present with elevated serum calcium levels.
The relationship of corticosteroids to prostaglandins is of interest. Prosta glandins are known to enhance bone resorption and therefore they may contribute to the development of hypercalcaemia during immobilisation. That immobilised bone is particularly sensitive to hormonal influences has been demonstrated by the now classical studies of Burkhart and Jowsey (1967) . It is plausible, therefore, that only moderately elevated prostaglandin blood levels may have an exaggerated osteolytic effect on bone of immobilised body parts. Two recent studies have shown that corticosteroids suppress the synthesis of prostaglandins and prosta glandin precursors (Kantrowitz et al., 1975; Tashjian et at., 1975) . It is conceiv able, therefore, that a decrease of endogenous cortisol formation may cause an increase of prostaglandin production, and that this in turn may contribute to an increase of bone resorption. This too may be a fruitful field for future research.
Immobilisation hypercalcaemia may not be as rare as the sparse reports in the literature suggest. Deitrick, Whedon and Shorr (1948) found elevated serum calcium levels in their healthy volunteers after they had been immobilised for 5 weeks or longer. Heath et al. (1972) found abnormal elevations of serum ionised calcium in nine out of ten patients who were immobilised for the treatment of fractures. Only three patients had an elevated total serum calcium. Hyper calcaemia may be asymptomatic. Symptoms, when they occur, are rather non specific and may easily be ascribed to depression or the effects of serious injury and prolonged bedrest.
It appears advisable to periodically determine serum calcium levels in patients in the early phase of spinal cord injury. If this were done, hypercalcaemia might be discovered more frequently.
Our patient developed hypercalcaemia while on a programme of intermittent catheterisation which had made it necessary to moderately restrict his fluid intake. Maynard and Imai (1977) also reported that two out of their four spinal cord injured hypercalcaemic patients were on a regime of fluid restriction while on a programme of intermittent catheterisation. Therefore, in adolescent tetraplegic or paraplegic patients fluid restriction may be unwise. If a programme of inter mittent catheterisation is initiated serum calcium levels should be obtained in frequent intervals.
SUMMARY
Hypercalcaemia is a rare complication of immobilisation. It almost always occurs in adolescent males who have become immobilised suddenly following a life of intense physical activity. This paper presents the case report of a Is-year old boy who developed hypercalcaemia 6 weeks after he had become tetraplegic in a diving accident. The treatment proved to be difficult. Calcitonin was effective only during the first 3 weeks of administration. Endocrinologic studies, however, indicated an adrenocortical insufficiency. As a result cortisone was administered in a small dosage as a replacement for the insufficient endogenous cortisol production.
The hypercalcaemia responded favourably. The serum calcium level fell promptly and remained within the normal range. This observa tion suggests that adrenocortical insufficiency may be an important factor in the development of immobilisation hypercalcaemia.
It is suggested that future observers investigate the adrenocortical function of immobilised patients who present with elevated serum calcium levels. RESUME L'hypercalcemie est une complication rare causee par l'immobilisation. Elle se produit presque toujours chez les adolescents du sexe masculin qui se trouvent immobilises soudaine ment apres une vie d'une tres grande activite physique. Ce papier presente Ie cas d'un jeune gar<;on de 15 ans qui developpa une hypercalcemie six semaines apres etre devenu quadriplegique a la suite d'un accident survenu en plongeant. Le traitement se revela difficile. La calcitonine administree ne fUt efficace que pendant les trois premieres semaines. Les etudes sur les glandes endocrines indiquerent cependant une insuffisance cortico surrenale. Par la suite, de la cortisone fut donnee par petites doses pour remplacer la production endogene insuffisante d'hydrocortisone.
L'hypercalcemie reagit favorable ment. Le niveau de serum de calcium tomba rapidement et demeura dans les limites normales. Cette observation donne a penser que l'insuffisance cortico-surrenale peut etre un facteur important dans Ie developpement de l'hypercalcemie resultant d'un etat immobile. Nous suggerons qu'a l'avenir les observateurs fassent des recherches sur la fonction cortico surrenale chez les patients immobilises presentant des niveaux eleves de serum de calcium. 
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